Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02843165
Title Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Diego

Advanced Solid Tumor


unspecified PD-L1 antibody

unspecified CTLA4 antibody

unspecified PD-1 antibody

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.